Enanta Pharmaceuticals
ENTA
#8030
Rank
A$0.55 B
Marketcap
A$18.98
Share price
-1.45%
Change (1 day)
47.86%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -A$77.18 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are A$69.21 Million. In 2025 the company made an earning of -A$89.27 Million, an increase over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$77.18 Million-13.55%
2025 -A$89.27 Million-34.07%
2024 -A$0.14 Billion-23.87%
2023 -A$0.18 Billion4.39%
2022 -A$0.18 Billion-4.4%
2021 -A$0.18 Billion91.12%
2020 -A$93.26 Million-407.13%
2019 A$30.36 M-78.63%
2018 A$0.14 B117.97%
2017 A$65.19 M-574.65%
2016 -A$13.74 Million-110.83%
2015 A$0.12 B-4.5%
2014 A$0.13 B-638.53%
2013 -A$24.67 Million-137.98%
2012 A$64.93 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.26 B-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.03 B-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
A$8.33 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$7.06 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.35 B-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.39 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA